Younger people, men and those without children more likely to drop out of HIV care in South Africa

Analysis carried out by an academic at Royal Holloway, University of London has revealed that younger people, men and those without children are more likely to stop attending clinics for HIV treatment in South Africa.

Dr Michael Evangeli, from the Department of Psychology at Royal Holloway, worked alongside colleagues at the University of Southampton and the University of KwaZulu Natal, South Africa. The academics used data collected in a study, which is published in the journal PLOS ONE, that followed the progress of 380 HIV positive people eligible for HIV treatment in a rural part of South Africa over a four year period and looked at what was associated with whether they dropped out of care.

Dr Evangeli, lead author of the study, said: "There is a pressing need to engage , and men, in long-term care. Medication for HIV is only given to those who are most unwell and they need to attend clinics regularly. Failing to attend is a problem for both the health of these individuals and for the health of others whom they may put at risk of HIV infection."

South Africa has the largest HIV positive population in the world – around six million people. One in five adults in South Africa are HIV positive.

"We need to improve our understanding of retention in care in future studies. Ultimately strategies must be put in place to help people remain in care and get the treatment they so desperately need to help slow down the spread of HIV and save as many lives as possible," added Dr Evangeli.

add to favorites email to friend print save as pdf

Related Stories

HIV and parenting needs to be discussed, new study finds

Nov 21, 2013

A team from Royal Holloway University and St. Mary's Hospital, London, interviewed young people aged 18-23 who had transmitted HIV from their mothers – known as 'perinatally acquired HIV' (PAH). Previously most of these ...

One in 10 South Africans HIV positive

May 14, 2013

One in ten South Africans is HIV positive but AIDS-related deaths are falling as ramped-up treatment begins to have an impact, the country's official statistics agency said Tuesday.

Recommended for you

Clinical trial of herpes vaccine now enrolling patients

Jul 28, 2014

Creating a successful vaccine against two members of the family, the sexually transmitted herpes simplex virus 1 (HSV-1) and 2 (HSV-2), has proven to be challenging. A clinical trial being conducted by a ...

User comments